Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes - PubMed (original) (raw)
. 1995 Jun 1;9(11):1340-53.
doi: 10.1101/gad.9.11.1340.
Affiliations
- PMID: 7797074
- DOI: 10.1101/gad.9.11.1340
Free article
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes
R L Beijersbergen et al. Genes Dev. 1995.
Free article
Abstract
The orderly progression through the cell cycle is mediated by the sequential activation of several cyclin/cyclin-dependent kinase (cdk) complexes. These kinases phosphorylate a number of cellular substrates, among which is the product of the retinoblastoma gene, pRb. Phosphorylation of pRb in late G1 causes the release of the transcription factor E2F from pRb, resulting in the transcriptional activation of E2F-responsive genes. We show here that phosphorylation of the pRb-related p107 is also cell cycle regulated. p107 is first phosphorylated at 8 hr following serum stimulation of quiescent fibroblasts, which coincides with an increase in cyclin D1 protein levels. Consistent with this, we show that a cyclin D1/cdk4 complex, but not a cyclin E/cdk2 complex, can phosphorylate p107 in vivo. Furthermore, phosphorylation of p107 can be abolished by the overexpression of a dominant-negative form of cdk4. Phosphorylation of p107 results in the loss of the ability to associate with E2F-4, a transcription factor with growth-promoting and oncogenic activity. A p107-induced cell cycle block can be released by cyclin D1/cdk4 but not by cyclin E/cdk2. These data indicate that the activity of p107 is regulated by phosphorylation through D-type cyclins.
Similar articles
- Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M, Gill RM, Hamel PA. Kiess M, et al. Cell Growth Differ. 1995 Oct;6(10):1287-98. Cell Growth Differ. 1995. PMID: 8845306 - The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I, Kitagawa M, Saijo M, Higashi H, Ogino H, Matsumoto H, Taya Y, Nishimura S, Okuyama A. Suzuki-Takahashi I, et al. Oncogene. 1995 May 4;10(9):1691-8. Oncogene. 1995. PMID: 7753545 - Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA. Cobrinik D, et al. Genes Dev. 1993 Dec;7(12A):2392-404. doi: 10.1101/gad.7.12a.2392. Genes Dev. 1993. PMID: 8253385 - Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. Sidle A, et al. Crit Rev Biochem Mol Biol. 1996 Jun;31(3):237-71. doi: 10.3109/10409239609106585. Crit Rev Biochem Mol Biol. 1996. PMID: 8817077 Review. - Melanoma cell autonomous growth: the Rb/E2F pathway.
Halaban R. Halaban R. Cancer Metastasis Rev. 1999;18(3):333-43. doi: 10.1023/a:1006396104073. Cancer Metastasis Rev. 1999. PMID: 10721488 Review.
Cited by
- The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Pathania AS, Chava H, Balusu R, Pasupulati AK, Coulter DW, Challagundla KB. Pathania AS, et al. Mol Ther Oncol. 2024 Feb 29;32(2):200785. doi: 10.1016/j.omton.2024.200785. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38595981 Free PMC article. Review. - Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation.
Tiwari D, Mittal N, Jha HC. Tiwari D, et al. Curr Res Neurobiol. 2022 Jun 30;3:100046. doi: 10.1016/j.crneur.2022.100046. eCollection 2022. Curr Res Neurobiol. 2022. PMID: 36685766 Free PMC article. Review. - Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.
Paternot S, Raspé E, Meiller C, Tarabichi M, Assié JB, Libert F, Remmelink M, Bisteau X, Pauwels P, Blum Y, Le Stang N, Tabone-Eglinger S, Galateau-Sallé F, Blanquart C, Van Meerbeeck JP, Berghmans T, Jean D, Roger PP. Paternot S, et al. Mol Oncol. 2024 Apr;18(4):866-894. doi: 10.1002/1878-0261.13351. Epub 2022 Dec 19. Mol Oncol. 2024. PMID: 36453028 Free PMC article. - Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.
Pogacar Z, Johnson JL, Krenning L, De Conti G, Jochems F, Lieftink C, Velds A, Wardak L, Groot K, Schepers A, Wang L, Song JY, van de Ven M, van Tellingen O, Medema RH, Beijersbergen RL, Bernards R, Leite de Oliveira R. Pogacar Z, et al. PLoS One. 2022 Sep 6;17(9):e0273182. doi: 10.1371/journal.pone.0273182. eCollection 2022. PLoS One. 2022. PMID: 36067171 Free PMC article. - MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer.
Portman N, Chen J, Lim E. Portman N, et al. Front Oncol. 2021 Nov 3;11:777867. doi: 10.3389/fonc.2021.777867. eCollection 2021. Front Oncol. 2021. PMID: 34804982 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials